![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 17, 14869-14876, April 26, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Renal Division, Washington University School of Medicine,
St. Louis, Missouri 63110
Received for publication, January 3, 2002, and in revised form, February 6, 2002
The multi-zinc finger proteins of the Sal family
regulate organogenesis. Genetic evidence from Drosophila
has shown that spalt (sal) can alter gene
expression in a cell autonomous fashion, but Sal proteins have never
been directly analyzed for their ability to activate or repress
transcription. In this report, we show that a member of the Sal family,
mouse Sall1, is a potent transcriptional repressor. When fused to a
heterologous DNA-binding domain, Sall1 represses transcription of a
luciferase reporter by over 100-fold. Expression of the N terminus
alone is sufficient for dose-responsive repression that, as shown by
deletion analysis, requires the extreme N-terminal amino acids of the
protein. The N terminus of Sall1 can repress at both short and long
range relative to the promoter, and treatment with the histone
deacetylase (HDAC) inhibitor, trichostatin A, alleviates repression by
3-fold. The same regions of the protein that are required for
repression physically interact with components of chromatin remodeling
complexes, HDAC1, HDAC2, RbAp46/48, MTA-1, and MTA-2. Finally, we
demonstrate that Sall1 is localized to discrete nuclear foci and this
localization depends on the N-terminal repression domain. Together,
these results suggest that the N terminus of mouse Sall1 can recruit
HDAC complexes to mediate transcriptional repression.
The transcriptional regulators of the spalt
(sal) gene family play an important role in regulating
developmental processes of many organisms. The most well studied
sal family members, Drosophila spalt-major
(salm) and spalt-related
(salr), specify cell fate decisions of
chordontonal precursors in the peripheral nervous system (1), regulate
tracheal development (2), control terminal differentiation of
photoreceptors (3), and determine proper placement of wing veins (4).
Mutations in the human sal ortholog, SALL1, cause
an autosomal dominant disorder, Townes-Brocks Syndrome, and
result in ear, limb, anal, renal, and heart anomalies (5). Targeted
deletion of mouse Sall1 results in severe renal dysplasia or
complete agenesis, indicating that Sall1 has an essential
role in kidney development (6).
Sal proteins are postulated to be transcriptional regulators because
their sequence contains multiple DNA-binding zinc finger motifs. Mouse
Sall1 has 10 zinc fingers (Fig. 1A). Nine are the C2H2-type (shaded gray) and are
arranged as doublets with a third finger associated with the second
pair. The second finger of each pair contains the conserved sequence
F(T/S)TKGNLK that has been termed the SAL-box (7). This
sequence is located in the predicted It has been suggested that Sal proteins may act as transcriptional
repressors in a variety of developmental contexts in Drosophila. sal inhibits expression of trachealess
(trh), ventral veinless (vvl), and
knirps (kni) in the developing trachea (2),
rhodopsin 1 (rh1) in differentiating
photoreceptors (3), and iriquois (iro) and
kni during development of the longitudinal veins (11). These
genetic experiments also indicate that sal-mediated
repression is cell autonomous, raising the possibility that Sal may
directly inhibit expression of these downsteam targets in
Drosophila. Despite this considerable genetic evidence
supporting a role for sal family members in the regulation
of gene expression, there is currently no evidence that Sal proteins
can directly mediate transcriptional repression.
Here we test whether mouse Sall1 is capable of directly affecting
transcriptional activity and provide the first direct evidence that Sal
proteins may act as transcriptional repressors. When linked to a
heterologous DNA-binding domain, the Sall1 protein is capable of
repressing transcription over 100-fold. We localize repressor activity
within the N terminus of the protein and suggest that histone
modification by HDACs1 is
involved in repression by Sall1. The dependence of Sall1-mediated repression on histone deacetylation is further confirmed by
demonstrating a physical association between HDAC complex components
and the N-terminal Sall1 repression domain. In addition, the ability of Sall1 to repress transcription correlates with localization of Sall1 in
focal nuclear subdomains that may be involved in recruiting Sall1 to
specific HDAC complexes within the nucleus.
cDNA Isolation--
Mouse Sall1 cDNA was
isolated by screening a mouse 129/SvJ kidney cDNA library with a
Sall1 EST clone (GenBankTM accession number
AA117993) by Incyte Genomics. Sequencing of the largest cDNA clone
(5.4 kb) showed that this clone encoded all but the initial ATG and 386 bases of the coding region of the mouse ortholog of human
SALL1. The remaining 5'-sequence was obtained by performing
5'-rapid amplification of cDNA ends on E17 RNA from mouse kidney
using the 5'/3'-rapid amplification of cDNA ends kit (Roche
Molecular Biochemicals) according to the manufacturer's
specifications. The full cDNA clone was reconstructed by PCR
amplification using Sall1-specific primers designed from the
subsequently published mouse Sall1 sequence (Ref. 12,
GenBankTM accession number AJ271914) and an internal
KpnI site.
Cell Culture and Transfection--
COS-1 cells were maintained
in Dulbecco's modified Eagle's medium containing 10% fetal bovine
serum, penicillin, and streptomycin. Cells were plated in 6-well plates
at a density of 1 × 105 cells per well and
transfected using FuGENE (Roche Molecular Biochemicals) according to
the manufacturer's directions.
Plasmids--
The GAL4DB expression plasmid, BXG-I, and the
eukaryotic GST fusion plasmid, pEBG, were graciously provided by R. Maas (Brigham and Women's Hospital) and S. Stefani (McGill University)
and used to construct the GAL4DB-Sall1 and GST-Sall1 fusions by PCR and restriction fragment subcloning. The following Sall1 fusion constructs were confirmed by sequencing and detection of the expressed fusion proteins by anti-GAL4DB or anti-GST Western blotting: full-length (amino acids 1-1322), N-terminal (2-435), C-terminal (1104-1322), Zn-finger (436-1103), and the N-terminal deletion constructs encoding amino acids 77-435, 130-435, 204-435, 266-435, and 399-435. The luciferase reporters were generous gifts from J. Milbrandt (SV40Luc, pG5SV40Luc, pG5-450bp-SV40Luc, pG5-2900bp-SV40Luc, and pG5AdMLPLuc, Washington University), R. Davis (pG5E1bLuc, University of
Massachusetts), and D. Moore (GAL4tkLuc, Baylor). MTA1-T7 and
MTA2-FLAG (PCIN4) were provided by R. Kumar (M.D. Anderson Cancer
Center) and W. Gu (Columbia University), respectively. The Sall1-FLAG
constructs were made using a p300-FLAG-pcDNA3 plasmid obtained from
J. Merchant (University of Michigan) by removing p300 and replacing it
with the full-length Sall1 sequence. The FLAG-tagged N-terminal
deletion constructs Sall1-(77-1322), Sall1-(130-1322),
Sall1-(204-1322) were generated by excising a 5'-fragment of
Sall1-FLAG with HindIII (5' end of cDNA) and
NheI (nucleotide 913) and replacing it with a
HindIII-NheI cut PCR fragment. These constructs
encode a full-length protein beginning with nucleotide 77, nucleotide
130, or nucleotide 204 and are FLAG-tagged at their C termini.
Reporter Assays--
Cells were transiently transfected with 1 µg of GAL4DB fusion plasmid, 2 µg of luciferase reporter plasmid,
and 0.05 µg of cytomegalovirus- Protein Interaction Assays--
Transfected cells were allowed
to express GST-Sall1 fusion proteins for 48-72 h, washed with
phosphate-buffered saline, and lysed for 1 h on ice with lysis
buffer (1% Triton X-100, 200 mM sucrose, 50 mM
Tris (pH 7.4), 150 mM NaCl, and inhibitors (1 µg/ml leupeptin, 2 µg/ml antipain, 10 µg/ml benzamidine, 1 µg/ml
chymostatin, 1 µg/ml pepstatin, 24 µg/ml Pefabloc, 20 mM NaF, and 2 mM sodium molybdate)). Cells were
scraped off the dishes and the cell suspension was sonicated (3 × 20 s). After removal of particulate cell debris by centrifugation
at 10,000 × g for 10 min, GST-Sall1 fusion protein complexes were isolated by precipitation of 50 µg of total protein (or 200 µg for the full-length GST fusion) with glutathione-Sepharose beads (Amersham Bioscience) for 2 h at 4 °C. The beads were
washed three times with 10 volumes of lysis buffer and eluted by
boiling in Laemmli sample buffer. GST-Sall1 fusions and
Sall1-interacting proteins were separated by SDS-polyacrylamide gel
electrophoresis on 7.5% gels, transferred to nitrocellulose, blocked
in 3% nonfat dry milk, and incubated with appropriate antibodies.
Antibody reactivity was detected using horseradish peroxidase-labeled
secondary antibodies (horseradish peroxidase anti-mouse (KPL) and
horseradish peroxidase anti-rabbit (Sigma)) and ECL detection reagent
(Amersham Pharmacia Biotech).
Immunofluorescence--
Cells were transfected on glass
coverslips and allowed to express for 48-72 h. The coverslips were
fixed in 3% paraformaldehyde, washed in phosphate-buffered saline
containing 50 mM glycine, permeablized in cold methanol,
and blocked in 10% normal goat serum (Sigma). Primary antibodies were
diluted in phosphate-buffered saline containing 1% bovine serum
albumin (anti-FLAG 1:200, anti-GAL4DB 1:50, and anti-Sall1 1:500) and
detected using fluorescein isothiocyanate anti-mouse (ICN) secondary
antibodies. All coverslips were incubated with 100 ng/ml Hoechst dye to
detect cell nuclei and mounted with Miowiol 4-88 (Polysciences, Inc.).
Images were visualized with a fluorescence (Nikon Eclipse E800) or
confocal (MRC1024 Bio-Rad) microscope. Greater than 200 cells from at
least 3 independent transfections were scored for each pattern of
nuclear staining (punctate, reticular, diffuse, see text).
Antibodies--
Polyclonal antisera were raised against an
N-terminal peptide of mouse Sall1, RRDGDTEKGQPSRPTKS (Strategic
Biosolutions). Anti-GAL4DB (RK5C1), anti-GST (B14), anti-HDAC2 (H-54),
and anti-Sin3A (AK-11) (Santa Cruz); anti-FLAG (M2) and anti-HDAC1
(Sigma); anti-T7 (Novagen); and anti-RbAp46/48 (15G12) (Genetex) were
all obtained from commercial sources.
Mouse Sall1 Represses Transcription--
The ability of mouse
Sall1 to affect transcription was analyzed by fusing the GAL4
DNA-binding domain (GAL4DB) to mouse Sall1. As depicted in Fig.
1A, the full-length protein
(1-1322), a N-terminal construct containing the C2HC zinc
finger (2-435), a C-terminal region containing one double zinc finger
pair (1104-1322), and a zinc finger domain containing seven
C2H2 zinc fingers (436-1103) were expressed as
GAL4DB fusion proteins and transfected with a GAL4-responsive
luciferase reporter. When assayed for its ability to activate or
repress a GAL4-responsive reporter, full-length mouse Sall1 was a very
strong transcriptional repressor (>100-fold). This repression activity
appears to be largely mediated by the N-terminal domain because it
alone is capable of potent repression. The C-terminal domain does not
have the ability to repress or activate transcription and the zinc
finger domain containing the remaining seven
C2H2 zinc fingers represses transcription to a lesser extent. DNA binding is required for Sall1 repression because expression of full-length Sall1 that lacks the GAL4 DNA-binding domain
does not repress transcription (data not shown).
Repression by Sall1 N Terminus Is Dose Responsive--
Because the
N terminus alone was shown to be a particularly powerful repressor, it
was analyzed in more detail to determine whether transcriptional
repression was dependent on Sall1 dosage. Increasing amounts of the
GAL4DB-Sall1-N fusion construct were transfected into cells to test for
their ability to repress luciferase expression. Increasing doses of
Sall1-N repressed luciferase activity in a dose-responsive manner (Fig.
1B). At the lowest amount of Sall1-N transfected (10 ng),
the luciferase activity was identical to the activity produced by
GAL4DB alone while at the highest amount of Sall1-N transfected (1 µg), the luciferase activity measured was less than 3% of the GAL4DB
control. The Sall1 N terminus was capable of repressing transcription
from two additional GAL4-responsive reporters containing the adenovirus
E1b promoter or the thymidine kinase promoter and in two different cell
lines (data not shown).
The Extreme N Terminus Mediates Repression--
To localize the
repression domain within the N terminus, a series of Sall1-N deletion
constructs were coexpressed with the GAL4-responsive SV40-luciferase
reporter. As depicted in Fig. 2, these
deletion constructs sequentially removed the C2HC zinc finger and regions rich in threonine, glutamine, and serine.
Interestingly, removal of the extreme N-terminal 76 amino acids
including the C2HC zinc finger, Sall1-N-(77-435),
significantly reduced the ability to repress transcription from over
100-fold to only 10-fold. A further deletion of the first 129 amino
acids, Sall1-N-(130-435), removes all of the repression activity of
the Sall1 N terminus and none of the smaller constructs regained this
ability to repress transcription. Our assay was able to detect both
transcriptional activation and repression because the GAL4
transactivation domain consistently increased luciferase activity more
than 10-fold (data not shown). Yet, despite the resemblance between the
glutamine-rich region of Sall1 and the activator domain of the
transcription factor Sp1 (7), none of the Sall1 N-terminal constructs
unmasked a region capable of activating transcription.
Repression at a Distance--
To determine whether repression was
dependent on the distance of the binding sites from the promoter
region, Sall1-N was targeted to GAL4-binding sites at different
distances from the SV40 promoter. The SV40 reporter used in the
previous experiments contained five GAL4-binding sites separated from
the SV40 promoter by 50 bp. This reporter, two additional constructs
that included intervening sequences of 450 and 2900 bp between the
GAL4-binding sites and the SV40 promoter, and a control plasmid that
removed all of the GAL4-binding sites upstream of the SV40 promoter
were tested for repression by co-transfection with Sall1-N. As shown in
Fig. 3A, all of the reporters
containing GAL4-binding sites (50, 450, and 2900 bp) were repressed by
Sall1-N to less than 3% of GAL4DB-transfected control (gray
bar) regardless of the length of the intervening sequence. This
repression was significantly different (p < 0.05) from
Sall1-N repression of a luciferase reporter with no GAL4-binding sites
(SV40, 25%) and the activity of the GAL4DB control was identical using
each of the three reporters (data not shown). Thus, Sall1-N is able to
repress transcription both close to and at a distance from the
promoter.
Repression Is Dependent on Histone Deacetylase
Activity--
Repression of transcription by many proteins close to
and at a distance from a promoter region has been shown to involve HDAC activity, therefore we tested whether Sall1-N repression required HDAC
activity using the HDAC inhibitor, TSA. Because TSA had a repressive effect on the baseline activity of the SV40 reporter in the
absence of Sall1, we utilized a GAL4-responsive luciferase reporter
driven by a different promoter for these assays. The adenovirus major
late promoter (AdMLP) is a well characterized promoter that is
sensitive to repression by HDACs and was not repressed by TSA in the
absence of Sall1 (13-15). Similar to the SV40-luciferase reporter,
transfection of Sall1-N fused to GAL4DB (Fig. 3B,
black bar) repressed the activity of the AdMLP luciferase reporter to 8% of GAL4DB-transfected controls (gray bar).
TSA treatment (stippled bars) increased this activity to
over 24% of GAL4-DB TSA-treated controls (p < 0.05).
This 3-fold relief of repression by an HDAC inhibitor suggests that
Sall1-N repression is, at least in part, HDAC dependent.
HDAC-dependent repression utilizes multiprotein complexes.
Therefore we next tested whether Sall1 could physically interact with
HDAC complex components. Two well characterized HDAC-containing complexes, NuRD and Sin3, have been shown to interact with sequence specific DNA-binding transcription factors, such as Ikaros (16) and
nuclear hormone receptors (reviewed in Ref. 17), and thereby mediate
transcriptional repression. Two HDAC enzymes, HDAC1 and HDAC2, and two
associated proteins, RbAp46 and RbAp48, are core components common to
both the NuRD and Sin3 repression complexes. NuRD and Sin3 differ by
the inclusion of NuRD-specific (MTA1, MTA2, Mi2, and MBD3) and
Sin3-specific (Sin3A, SAP18, and SAP30) factors to alter chromatin
structure and repress transcription via distinct DNA-binding
transcription factors (reviewed in Ref. 18).
To test for a physical interaction between Sall1 and HDAC complexes,
the same regions of Sall1 that were expressed as GAL4DB fusion proteins
were subcloned into a GST fusion expression vector, pEBG, and
overexpressed in COS-1 cells. GST-Sall1 fusion proteins were isolated
on glutathione-Sepharose beads and analyzed by Western blotting. All
GST-Sall1 proteins were expressed at similar levels except for the
largest fusion, full-length Sall1, which was at least 4-fold less well
expressed (data not shown) and required 4-fold more of the cell lysate
to be used in the precipitation (see "Experimental
Procedures").
When the GST-Sall1 precipitates were analyzed for the ability to
directly or indirectly bind HDAC repression complex proteins, the same
regions of Sall1 that mediated strong repression, the full-length
protein (1-1322) and the N terminus (2-435), interacted with
repression components (Fig.
4A). Endogenous HDAC1, HDAC2, and RbAp46/48, core components of all HDAC repression complexes, bound
to N-terminal and full-length GST fusion proteins, but not to the
C-terminal or zinc finger proteins or to GST alone.
To discern whether Sall1 interacted with the Sin3 or NuRD repression
complex, we next tested whether these GST-Sall1 proteins could bind to
Sin3A or to the NuRD-specific components, MTA1 and MTA2. MTA1-T7 and
MTA2-FLAG were coexpressed with GST-Sall1 fusions and, like HDAC1/2 and
RbAp46/48, were able to bind full-length and N-terminal Sall1 fusion
proteins, but not the C-terminal or zinc finger regions. Interestingly,
another NuRD complex component, Mi2, was not detectable in the
GST-Sall1 precipitates (data not shown), suggesting that not all NuRD
components were present in the active Sall1 repression complex.
However, since Sin3A does not bind any GST-Sall1 fusion proteins, the
active Sall1 repressor complex likely resembles NuRD and not Sin3.
The correlation between strong transcriptional repression and NuRD
complex interaction was evident for the N-terminal deletions of Sall1
(Fig. 4B). When the N terminus and the three longest deletion constructs (77-435, 130-435, and 204-435) were expressed as
GST fusion proteins in COS-1 cells and purified on
glutathione-Sepharose, only Sall1-N was able to interact with HDAC1,
HDAC2, RbAp46/48, MTA1-T7, and MTA2-FLAG. Since this region was also
capable of the most potent repression, this suggests that the first 76 amino acids of Sall1 are required for repression through their
interaction with components of the NuRD complex.
Sall1 Is Localized to Nuclear Foci through Its N
Terminus--
Because transcriptional regulators have been shown to
localize in discrete subdomains within the nucleus (19), we next
examined the cellular localization of the Sall1 protein.
Immunofluorescence of cells overexpressing a full-length FLAG-tagged
Sall1 protein demonstrated that Sall1 is found in the nucleus in
discrete punctate foci (Fig.
5A, top panels).
This pattern was evident in ~70% of transfected cells using a
monoclonal antibody that recognized the C-terminal FLAG epitope and the
anti-Sall1 polyclonal antisera directed against an N-terminal peptide
(data not shown) indicating that this punctate localization was easily
detectable by multiple reagents.
Similar punctate nuclear foci were also detected in cells expressing
GAL4DB-Sall1-N (Fig. 5A, bottom panel)
demonstrating that the N-terminal domain of Sall1 was sufficient for
localization to these discrete nuclear subdomains. Notably, the
presence of the canonical nuclear localization sequence in GAL4DB was
also required because GST-Sall1-N was not localized to the nucleus (data not shown). Thus, while the N-terminal domain of Sall1 does not
appear to contain a functional nuclear localization signal, it does
contain a domain that targets Sall1 to discrete nuclear foci once Sall1
has entered the nucleus.
Sall1 Localization Correlates with Repression--
Since Sall1-N
was an active repressor, bound to HDAC complexes, and was sufficient to
localize Sall1 to discrete nuclear foci, we next sought to determine
whether the presence of Sall1 in nuclear foci correlated with its
ability to repress. In contrast to the punctate staining observed for
most cells expressing Sall1-N, N-terminal deletions that significantly
reduced or abolished repression by Sall1 altered the subnuclear
localization. Three different patterns of Sall1 nuclear staining were
observed and are represented in Fig. 5B: punctate (top
panels), reticular (middle panels), and diffuse
(bottom panels). Deletion of the first 76 amino acids from
the N terminus resulted in a 10-fold reduction in repression (Fig. 2)
and reduced the number of cells exhibiting punctate nuclear staining
(16%) compared with Sall1-N (66%, top left panel). The remainder of the Sall1-N-(77-435) expressing cells exhibited a reticular (32%, middle left panel) or diffuse (52%)
nuclear staining pattern and were clearly distinct from the discrete
punctate pattern. A larger N-terminal deletion that removed 129 amino
acids and completely abrogated repression (Fig. 2) exhibited a
predominantly diffuse nuclear pattern of staining (83%, bottom
left panel). Thus, deletion of a region of the N-terminal of Sall1
that is required for transcriptional repression alters the nuclear
localization of Sall1 from a predominantly punctate nuclear
distribution to a diffuse or reticular pattern of nuclear staining.
To confirm these results in the context of the intact Sall1 protein and
its native nuclear localization sequence, the same deletion constructs
that were expressed as N-terminal Sall1 GAL4DB and GST fusion proteins
for the repression and interaction studies were made as FLAG-tagged
proteins containing the zinc finger and C-terminal domains. Similar to
the results observed with the GAL4DB N-terminal fusion proteins,
Sall1-(77-1322) exhibited a punctate pattern of nuclear staining in
only 18% of cells compared with 67% for full-length Sall1 (Fig.
5B, top right panel). The remainder of the
Sall1-(77-1322) expressing cells exhibited either diffuse nuclear
staining (56%) or a reticular pattern of nuclear staining (26%,
middle right panel). Sall1-(130-1322), the deletion
analogous to the N-terminal construct that completely abrogated
Sall1-mediated repression (Fig. 2), exhibited diffuse nuclear staining
in the majority of expressing cells (79%, bottom right
panel). Sall1-N-(204-435), a larger N-terminal deletion construct
that also does not repress transcription (Fig. 2) displayed a
predominantly diffuse nuclear staining pattern that was
indistinguishable from Sall1-(130-1322) (data not shown). Together,
these results strongly suggest that localization to discrete, punctate
nuclear foci is necessary for full transcriptional repression by Sall1.
In this report we provide the first direct evidence that the
multi-zinc finger protein mouse Sall1 is a potent repressor of transcription. This conclusion is consistent with the genetic evidence
in Drosophila that sal inhibits expression of
multiple genes in a cell autonomous manner (2, 3, 11). The
demonstration that Sall1 is a strong transcriptional repressor does not
exclude the possibility that it could also function as a
transcriptional activator in some contexts. In patterning
Drosophila wing veins, the two sal family
members, salm and salr, repress genes when they
are highly expressed, but also can activate gene transcription at lower
expression levels (11). This study examined the ability of Sall1 to
control transcription in an overexpression system and thereby
highlighted a role for Sall1 in transcriptional repression. However, to
date our analysis of Sall1 in vitro has not uncovered a
domain that activates
transcription.2
The Sall1 N terminus alone is capable of strong transcriptional
repression. This region contains a C2HC zinc finger and
domains rich in threonine, glutamine, and serine. The C2HC
zinc finger region, and not the threonine, glutamine, or serine-rich
domains, is necessary for potent repression because truncation of the
extreme N terminus reduces repression activity by 10-fold. The
glutamine-rich domain has been postulated to mediate transcriptional
activation (7), but this domain did not contribute to activation or
repression in the experiments presented here. Within the region
required for repression, all vertebrate Sal proteins contain a
homologous C2HC zinc finger and a 20-amino acid region at
their extreme N termini. Further studies are underway to test whether
these regions are sufficient to repress transcription or whether
additional regions cooperate to achieve full transcriptional repression
by the N terminus of mouse Sall1.
The Drosophila Sal family members do not encode a
C2HC zinc finger domain and do not share any apparent
homology with vertebrate Sal proteins at their N termini. However,
although not investigated in detail in this report, our data also
demonstrate that Sall1 contains another repression domain in a region
of the protein that includes the DNA-binding
C2H2 zinc fingers and this domain appears to
repress independently of HDAC (Figs. 1A and 4A).
Since the C2H2 zinc fingers are highly
conserved between fly and vertebrate Sal, one possibility is that
Drosophila Sal mediates repression via this region of the
protein. The N-terminal repression domain identified in this study may
have been recruited later in evolution and may serve a unique function
in vertebrate development. The presence of multiple independent
repression domains in transcription factors, in some cases overlapping
with the DNA-binding domain, has been demonstrated for other factors,
such as Brinker, Hesx1, and ZEB (20-22). In the case of Brinker, the
two domains employ different co-repressor molecules to mediate
transcriptional repression. These domains can function independently or
cooperatively to repress dpp-responsive genes (22). Whether
a similar paradigm applies to Sall1 remains to be established.
The role of the mouse Sall1 N terminus in transcriptional repression
has a potential implication for patients with human SALL1 mutations. A hotspot for mutations that cause Townes-Brocks Syndrome birth defects occurs in the region before the first set of double zinc
fingers (6, 23). Some of these mutations cause premature stop codons
and, if a truncated protein were expressed from these mutated alleles,
that protein would encode only the N-terminal domain. Because the
region of mouse Sall1 required for repression (amino acids 1-130) are
99% identical to human SALL1, the experiments presented here suggest
that this truncated protein would be an extremely powerful
transcriptional repressor. The repression domain would be untethered
from the DNA-binding region of SALL1 but, according to our results,
could still interact with repression complexes. This unregulated
repressor could be a major factor in the phenotype of Townes-Brocks
Syndrome possibly by conferring dominant negative activity as a
nonspecific transcriptional regulator.
Because murine Sall1 can repress transcription close to and at a
distance from the promoter and the HDAC-inhibitor TSA can alleviate
some of the repression, HDAC complexes may mediate transcriptional inhibition by Sall1. This hypothesis is further substantiated by the
fact that the same Sall1 constructs that repress, the full-length protein and the first 435 N-terminal amino acids can also interact with
HDAC complex components. However, since Sall1 repression is only
partially relieved by HDAC inhibitors, it is likely that deacetylase
enzyme activity is augmented by other repression mechanisms to mediate
strong inhibition of gene transcription in the Sall1 repressor complex.
It also remains to be determined which, if any, of the HDAC complex
components interact with Sall1 directly. The protein directly
responsible for Sall1 association with HDAC complexes requires the
first 76 amino acids of Sall1 for binding and could be HDAC itself.
Regardless of the identity of the direct Sall1-binding protein(s), the
strict association between strong repression and HDAC complex
interaction suggests that a large multiprotein complex is responsible
for Sall1 repression of target genes. Such a model is similar to that
proposed for other transcription factors, such as the zinc finger
protein Ikaros (16). However, while Ikaros-containing complexes display
both ATP-dependent chromatin remodeling and histone
deacetylation activities, we were unable to detect the NuRD-associated
DNA-dependent ATPase Mi2 in a complex with Sall1. Thus,
either Sall1 does not recruit chromatin remodeling ATPase activity or
alternatively it recruits a chromatin-remodeling complex independent of
NuRD, such as SWI/SNF. It is also possible that Sall1 assembles a
unique HDAC-containing complex related to NuRD, similar to that
identified for nuclear receptors in matrix-associated deacetylase
bodies (24). A definitive characterization of the active Sall1
repression complex will require analysis using an endogenous target gene.
The N-terminal region of Sall1 that also contains the repression domain
is required for cellular localization of Sall1 in discrete, punctate
nuclear foci. Transcriptional modulators are often found in this type
of localization pattern and have been described as components of
nuclear subdomains termed splicing factor speckles, coiled bodies,
PML oncogenic domains (reviewed in Ref. 25), or
matrix-associated deacetylase bodies (24). Localization of the
transcriptional repressors Ikaros and the Kruppel-associated
box-containing zinc finger proteins to heterochromatin is implicated as
a mechanism of heritable gene silencing and these proteins also display
a punctate nuclear staining pattern (26-30). Thus, considerable
evidence indicates that discrete nuclear subdomains may be used to
concentrate repressor complexes. Our data strongly suggest that
localization to punctate nuclear foci is important for Sall1 to
function as a potent repressor. While we have determined that Sall1
does not co-localize with SC-35 (data not shown), a protein that is
found in a speckled nuclear subdomain enriched for splicing factors, it
remains to be determined if Sall1 foci correspond to the subdomains
described for repressor complexes such as PML or
matrix-associated deacetylase bodies.
In summary, we provide the first evidence that mouse Sall1 is a direct
transcriptional repressor. This repression is dependent, at least in
part, on HDAC activity and likely involves a large multiprotein complex
that includes factors associated with NuRD. The extreme N-terminal
domain mediates repression and is necessary for Sall1 localization to
nuclear foci that are likely essential for repressor function. It will
be important to identify in vivo target genes regulated by
Sall1 to determine the biochemical mechanism of Sall1 repression.
We thank J. Cordero for assistance with
confocal microscopy, D. P. Kelly for luminometer use, J. R. Kiefer for help with figure preparation, and S. W. McLeskey for
critical reading of this manuscript.
During submission of this manuscript,
human SALL1 was also shown to repress transcription and localize to
pericentromeric heterochromatin foci by another group (Netzer, C.,
Rieger, L., Brero, A., Zhang, C-D., Hinzke, M., Kohlhase, J., and
Bohlander, S. L. (2001) Hum. Mol. Genet. 10, 3017-3024).
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom all correspondence should be addressed. Tel.: 314-362-8253;
Fax: 314-362-8237; E-mail: mrauchma@im.wustl.edu.
Published, JBC Papers in Press, February 8, 2002, DOI 10.1074/jbc.M200052200
2
S. Kiefer and M. Rauchman, unpublished observations.
The abbreviations used are:
HDAC, histone
deacetylase;
TSA, trichostatin A;
GAL4DB, GAL4 DNA-binding domain;
GST, glutathione S-transferase;
AdMLP, adenovirus major late
promoter.
Murine Sall1 Represses Transcription by Recruiting a Histone
Deacetylase Complex*
,
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-helical region of the zinc
finger that specifies the nucleotide consensus binding sequence and is
thought to bind A/T-rich sequences (8, 9). However, the native
DNA-binding site and direct target genes regulated by Sal proteins have
not yet been determined. The most N-terminal zinc finger is of the
C2HC-type (solid gray) and may mediate
protein-protein interactions rather than DNA binding (reviewed in Ref.
10).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-galactosidase control plasmid per
well. pcDNA3 (Invitrogen) was used to normalize the DNA content of
the transfection. When appropriate, cells were treated with 200 nM trichostatin (TSA, Calbiochem) or an equivalent volume
of Me2SO vehicle for 24 h prior to harvesting for
reporter assays. After 48 h, the transfected cells were washed
with phosphate-buffered saline, lysed with reporter assay lysis buffer
(Promega), and spun at 10,000 × g to pellet cell
debris. The supernatant was then assayed for luciferase and
-galactosidase activity using the manufacturer's suggested
protocols (luciferase, BD PharMingen;
-galactosidase, PE Biosystems)
with 15 or 2.5% of the total lysate, respectively. Luminescent
reporter activity was measured using a Monolight Luminometer (BD
PharMingen). All transfections were normalized to
-galactosidase activity and performed in triplicate. Statistical significance of TSA-
versus Me2SO-treated samples was determined by
one-tailed Student's t test.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (16K):
[in a new window]
Fig. 1.
Transcriptional repression by Sall1.
A, the mouse Sall1 protein contains one C2HC
zinc finger (solid gray) and nine
C2H2 zinc fingers (shaded gray)
arranged in pairs. The full-length protein, the N terminus, the C
terminus, and a zinc finger region of Sall1 were expressed as GAL4DB
fusion proteins along with a reporter in which luciferase gene
transcription is under the control of five GAL4DB-binding sites and the
SV40 promoter (pG5SV40Luc). Fold repression was calculated by dividing
the normalized luciferase activity of cells expressing GAL4DB alone by
the activity of the Sall1 fusion protein. Values are plotted as the
mean ± S.D. of triplicate transfections from two independent
experiments and demonstrate that the full-length and N terminus of
Sall1 exhibit potent repression activity. B, increasing
doses of GAL4DB-Sall1-N (10, 100, 250, 500, and 1000 ng) or GAL4DB
alone was expressed with the luciferase reporter and
cytomegalovirus-
-galactosidase as in A. Normalized
luciferase measurements were divided by the activity for GAL4DB alone
and multiplied by 100 to calculate percent luciferase activity in
arbitrary units. Percent luciferase activity is plotted to highlight
the dose response of repression of Sall1-N compared with the control,
GAL4DB. Values are plotted as the mean ± S.D. of triplicate
transfections from three independent experiments.

View larger version (13K):
[in a new window]
Fig. 2.
Repression is mediated by the N-terminal
amino acids of Sall1. The Sall1 N terminus contains a
C2HC zinc finger (gray oval), a threonine-rich
domain (Thr), a glutamine-rich domain (Gln), and
a serine-rich domain (Ser). The N terminus (amino acids
2-435) and constructs sequentially deleting these domains or their
intervening sequences, N-(77-435), N-(130-435), N-(204-435),
N-(266-435), N-(399-435), were expressed as GAL4DB fusions, tested
for their ability to repress luciferase transcription, and plotted as
fold repression as described in the legend to Fig. 1A.

View larger version (20K):
[in a new window]
Fig. 3.
Sall1 repression occurs at short and long
range and is HDAC-dependent. A,
GAL4DB-Sall1-N (black bars) was expressed with luciferase
reporters containing no GAL4DB-binding sites (SV40) or five
GAL4DB-binding sites located either adjacent to (50 bp) or separated
from the SV40 promoter by 450 or 2900 base pairs and assayed for
luciferase activity as described in the legend to Fig. 1B.
Activity of the appropriate reporter in the presence of GAL4DB alone
(gray bar) has been set to 100% and is presented as the
mean ± S.D. of triplicate transfections from three independent
experiments. *, p < 0.05 for SV40 versus
GAL4-responsive (50, 450, and 2900 bp) reporters. B,
GAL4DB-Sall-N (black bars) or GAL4DB alone (gray
bars) were coexpressed in cells with a the pG5AdMLP luciferase
reporter for 24 h, treated with 200 nM TSA
(diagonal stripes) or Me2SO vehicle (solid
bars), and assayed 24 h later. Me2SO- and
TSA-treated Sall1-N repression is presented relative to the luciferase
activity of GAL4DB in the absence or presence of TSA from triplicate
transfections. Error bars represent the standard deviation
from three independent experiments. *, p < 0.05 for
TSA- versus vehicle-treated GAL4DB-Sall1-N transfected
cells.

View larger version (31K):
[in a new window]
Fig. 4.
Sall1-N interacts with HDAC complex
components. The same regions of Sall1 that mediate strong
repression, interact with HDAC1, HDAC2, RbAp46/48, MTA1, and MTA2, but
not Sin3A. A, whole cell extracts prepared from cells
transfected with GST alone or GST fused to the N terminus, C terminus,
zinc finger, or full-length Sall1 proteins were incubated with
glutathione-Sepharose, washed, and eluted in sample buffer. These
eluates and one-tenth (5 µg) of the GST expressing input lysate were
analyzed for the presence of endogenous HDAC complex components by
Western blotting using anti-HDAC1, anti-HDAC2, anti-RbAp46/48, and
anti-Sin3A antibodies. MTA1-T7 and MTA2-FLAG were coexpressed with the
GST constructs prior to cell lysis and detected by anti-T7 or anti-FLAG
antibodies. B, glutathione-Sepharose precipitates from
N-terminal GST fusion proteins Sall1-N, the deletion constructs,
N-(77-435), N-(130-435), N-(204-435), and one-tenth (5 µg) of the
Sall1-N-expressing lysate were analyzed for HDAC complex components as
in A.

View larger version (38K):
[in a new window]
Fig. 5.
Localization of Sall1 to punctate nuclear
foci correlates with repression. Immunolocalization of
Sall1 and N-terminal deletions of Sall1 in transfected COS-1 cells.
A, cells grown on glass coverslips were transfected with
full-length Sall1-FLAG or GAL4DB-Sall1-N, stained with anti-FLAG or
anti-GAL4DB antibodies (green) and counterstained with
Hoechst dye (blue) to identify the nucleus. Cells were
viewed with epifluorescence and photographed with a SPOT2 digital
camera. B, cells were transfected with corresponding
deletions of full-length GAL4DB-Sall1-N (right panels) or
Sall1-FLAG (left panels), stained with anti-FLAG or
anti-GAL4DB antibody, and viewed by confocal microscopy. The staining
patterns observed were: punctate (top panels), reticular
(middle panels), or diffuse (bottom panels). The
table on the far right indicates the percentage of cells
that displayed the indicated staining pattern for GAL4DB fusion
constructs, however, the FLAG-tagged constructs exhibited very similar
results (see text). Greater than 200 expressing cells from at least
three independent transfections were scored.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
ACKNOWLEDGEMENTS
![]()
Note Added in Proof
![]()
FOOTNOTES
Supported by National Instiutes of Health Training Grant 5T32DK07126.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Elstob, P. R.,
Brodu, V.,
and Gould, A. P.
(2001)
Development
128,
723-732[Abstract] 2.
Boube, M.,
Llimargas, M.,
and Casanova, J.
(2000)
Mech. Dev.
91,
271-278[CrossRef][Medline]
[Order article via Infotrieve] 3.
Mollereau, B.,
Dominguez, M.,
Webel, R.,
Colley, N. J.,
Keung, B.,
de Celis, J. F.,
and Desplan, C.
(2001)
Nature
412,
911-913[CrossRef][Medline]
[Order article via Infotrieve] 4.
de Celis, J. F.,
Barrio, R.,
and Kafatos, F. C.
(1996)
Nature
381,
421-424[CrossRef][Medline]
[Order article via Infotrieve] 5.
Kohlhase, J.,
Wischermann, A.,
Reichenbach, H.,
Froster, U.,
and Engel, W.
(1998)
Nat. Genet.
18,
81-83[CrossRef][Medline]
[Order article via Infotrieve] 6.
Nishinakamura, R.,
Matsumoto, Y.,
Nakao, K.,
Nakamura, K.,
Sato, A.,
Copeland, N. G.,
Gilbert, D. J.,
Jenkins, N. A.,
Scully, S.,
Lacey, D. L.,
Katsuki, M.,
Asashima, M.,
and Yokota, T.
(2001)
Development
128,
3105-3115[Medline]
[Order article via Infotrieve] 7.
Kuhnlein, R. P.,
Frommer, G.,
Friedrich, M.,
Gonzalez-Gaitan, M.,
Weber, A.,
Wagner-Bernholz, J. F.,
Gehring, W. J.,
Jackle, H.,
and Schuh, R.
(1994)
EMBO J.
13,
168-179[Medline]
[Order article via Infotrieve] 8.
Pabo, C. O.,
and Sauer, R. T.
(1992)
Annu. Rev. Biochem.
61,
1053-1095[CrossRef][Medline]
[Order article via Infotrieve] 9.
Barrio, R.,
Shea, M. J.,
Carulli, J.,
Lipkow, K.,
Gaul, U.,
Frommer, G.,
Schuh, R. J. H.,
and Kafatos, F. C.
(1996)
Dev. Genes Evol.
206,
315-325[CrossRef] 10.
Laity, J. H.,
Lee, B. M.,
and Wright, P. E.
(2001)
Curr. Opin. Struct. Biol.
11,
39-46[CrossRef][Medline]
[Order article via Infotrieve] 11.
de Celis, J. F.,
and Barrio, R.
(2000)
Mech. Dev.
91,
31-41[CrossRef][Medline]
[Order article via Infotrieve] 12.
Buck, A.,
Archangelo, L.,
Dixkens, C.,
and Kohlhase, J.
(2000)
Cytogenet. Cell Genet.
89,
150-153[CrossRef][Medline]
[Order article via Infotrieve] 13.
Luo, R. X.,
Postigo, A. A.,
and Dean, D. C.
(1998)
Cell
92,
463-473[CrossRef][Medline]
[Order article via Infotrieve] 14.
Laherty, C. D.,
Yang, W. M.,
Sun, J. M.,
Davie, J. R.,
Seto, E.,
and Eisenman, R. N.
(1997)
Cell
89,
349-356[CrossRef][Medline]
[Order article via Infotrieve] 15.
Hassig, C. A.,
Fleischer, T. C.,
Billin, A. N.,
Schreiber, S. L.,
and Ayer, D. E.
(1997)
Cell
89,
341-347[CrossRef][Medline]
[Order article via Infotrieve] 16.
Kim, J.,
Sif, S.,
Jones, B.,
Jackson, A.,
Koipally, J.,
Heller, E.,
Winandy, S.,
Viel, A.,
Sawyer, A.,
Ikeda, T.,
Kingston, R.,
and Georgopoulos, K.
(1999)
Immunity
10,
345-355[CrossRef][Medline]
[Order article via Infotrieve] 17.
Xu, L.,
Glass, C. K.,
and Rosenfeld, M. G.
(1999)
Curr. Opin. Genet. Dev.
9,
140-147[CrossRef][Medline]
[Order article via Infotrieve] 18.
Ahringer, J.
(2000)
Trends Genet.
16,
351-356[CrossRef][Medline]
[Order article via Infotrieve] 19.
Hendzel, M. J.,
Kruhlak, M. J.,
MacLean, N. A.,
Boisvert, F.,
Lever, M. A.,
and Bazett-Jones, D. P.
(2001)
J. Steroid Biochem. Mol. Biol.
76,
9-21[CrossRef][Medline]
[Order article via Infotrieve] 20.
Postigo, A. A.,
and Dean, D. C.
(1999)
Mol. Cell. Biol.
19,
7961-7971 21.
Dasen, J. S.,
Barbera, J. P.,
Herman, T. S.,
Connell, S. O.,
Olson, L., Ju, B.,
Tollkuhn, J.,
Baek, S. H.,
Rose, D. W.,
and Rosenfeld, M. G.
(2001)
Genes Dev.
15,
3193-3207 22.
Hasson, P.,
Muller, B.,
Basler, K.,
and Paroush, Z.
(2001)
EMBO J.
20,
5725-5736[CrossRef][Medline]
[Order article via Infotrieve] 23.
Kohlhase, J.,
Taschner, P. E.,
Burfeind, P.,
Pasche, B.,
Newman, B.,
Blanck, C.,
Breuning, M. H.,
ten Kate, L. P.,
Maaswinkel-Mooy, P.,
Mitulla, B.,
Seidel, J.,
Kirkpatrick, S. J.,
Pauli, R. M.,
Wargowski, D. S.,
Devriendt, K.,
Proesmans, W.,
Gabrielli, O.,
Coppa, G. V.,
Wesby-van Swaay, E.,
Trembath, R. C.,
Schinzel, A. A.,
Reardon, W.,
Seemanova, E.,
and Engel, W.
(1999)
Am. J. Hum. Genet.
64,
435-445[CrossRef][Medline]
[Order article via Infotrieve] 24.
Downes, M.,
Ordentlich, P.,
Kao, H. Y.,
Alvarez, J. G.,
and Evans, R. M.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
10330-10335 25.
Lamond, A. I.,
and Earnshaw, W. C.
(1998)
Science
280,
547-553 26.
Cobb, B. S.,
Morales-Alcelay, S.,
Kleiger, G.,
Brown, K. E.,
Fisher, A. G.,
and Smale, S. T.
(2000)
Genes Dev.
14,
2146-2160 27.
Matsuda, E.,
Agata, Y.,
Sugai, M.,
Katakai, T.,
Gonda, H.,
and Shimizu, A.
(2001)
J. Biol. Chem.
276,
14222-14229 28.
Brown, K. E.,
Guest, S. S.,
Smale, S. T.,
Hahm, K.,
Merkenschlager, M.,
and Fisher, A. G.
(1997)
Cell
91,
845-854[CrossRef][Medline]
[Order article via Infotrieve] 29.
Brown, K. E.,
Baxter, J.,
Graf, D.,
Merkenschlager, M.,
and Fisher, A. G.
(1999)
Mol. Cell
3,
207-217[CrossRef][Medline]
[Order article via Infotrieve] 30.
Ryan, R. F.,
Schultz, D. C.,
Ayyanathan, K.,
Singh, P. B.,
Friedman, J. R.,
Fredericks, W. J.,
and Rauscher, F. J., III
(1999)
Mol. Cell. Biol.
19,
4366-4378
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. J. Harrison, R. Nishinakamura, and A. P. Monaghan Sall1 Regulates Mitral Cell Development and Olfactory Nerve Extension in the Developing Olfactory Bulb Cereb Cortex, July 1, 2008; 18(7): 1604 - 1617. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yang, L. Chai, F. Liu, L. M. Fink, P. Lin, L. E. Silberstein, H. M. Amin, D. C. Ward, and Y. Ma Bmi-1 is a target gene for SALL4 in hematopoietic and leukemic cells PNAS, June 19, 2007; 104(25): 10494 - 10499. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yamashita, A. Sato, M. Asashima, P.-C. Wang, and R. Nishinakamura Mouse homolog of SALL1, a causative gene for Townes-Brocks syndrome, binds to A/T-rich sequences in pericentric heterochromatin via its C-terminal zinc finger domains. Genes Cells, February 1, 2007; 12(2): 171 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Lauberth and M. Rauchman A Conserved 12-Amino Acid Motif in Sall1 Recruits the Nucleosome Remodeling and Deacetylase Corepressor Complex J. Biol. Chem., August 18, 2006; 281(33): 23922 - 23931. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sakaki-Yumoto, C. Kobayashi, A. Sato, S. Fujimura, Y. Matsumoto, M. Takasato, T. Kodama, H. Aburatani, M. Asashima, N. Yoshida, et al. The murine homolog of SALL4, a causative gene in Okihiro syndrome, is essential for embryonic stem cell proliferation, and cooperates with Sall1 in anorectal, heart, brain and kidney development Development, August 1, 2006; 133(15): 3005 - 3013. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Harvey and M. P. O. Logan sall4 acts downstream of tbx5 and is required for pectoral fin outgrowth. Development, March 1, 2006; 133(6): 1165 - 1173. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Munoz-Sanjuan and A. H. Brivanlou Induction of Ectopic Olfactory Structures and Bone Morphogenetic Protein Inhibition by Rossy, a Group XII Secreted Phospholipase A2 Mol. Cell. Biol., May 1, 2005; 25(9): 3608 - 3619. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Lin, A. E. Roche, J. Wilk, and E. C. Svensson The N Termini of Friend of GATA (FOG) Proteins Define a Novel Transcriptional Repression Motif and a Superfamily of Transcriptional Repressors J. Biol. Chem., December 31, 2004; 279(53): 55017 - 55023. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-L. Jiang, S.-G. Jin, and G. P. Pfeifer MBD3L1 Is a Transcriptional Repressor That Interacts with Methyl-CpG-binding Protein 2 (MBD2) and Components of the NuRD Complex J. Biol. Chem., December 10, 2004; 279(50): 52456 - 52464. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Parrish, T. Ott, C. Lance-Jones, G. Schuetz, A. Schwaeger-Nickolenko, and A. P. Monaghan Loss of the Sall3 Gene Leads to Palate Deficiency, Abnormalities in Cranial Nerves, and Perinatal Lethality Mol. Cell. Biol., August 15, 2004; 24(16): 7102 - 7112. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.E. Hoei-Hansen, J.E. Nielsen, K. Almstrup, M.A. Hansen, N.E. Skakkebaek, E. Rajpert-DeMeyts, and H. Leffers Identification of genes differentially expressed in testes containing carcinoma in situ Mol. Hum. Reprod., June 1, 2004; 10(6): 423 - 431. [Abstract] [Full Text] [PDF] |
||||
![]() |
|